User login
Enter your username and password here in order to log in on the website:
Tags
- ABPA_Aspergillus
- accompanying diseases
- air-improving devices
- allergy
- animals_pets
- antibiotic therapy
- asthma
- complementary medicine
- covid-19
- diabetes
- diagnostics
- drugs side effects
- drugs under development_genetic therapy
- ENT
- general aspects
- genetics
- health care
- hepatobiliary disease
- hygiene
- i.v.-lines
- inhalation
- lung
- microbiology
- miscellaneous
- modulator therapy
- MRSA
- nutrition and GI problems
- oxygen supplementation_therapy
- physiotherapy
- Pseudomonas aeruginosa
- psychosocial
- public facilities
- recreational activities
- reproduction
- research
- social law
- sport
- swine flu_novel influenza
- transplantation
- travelling
- vaccination
- ventilation
Topics
- Sweat test
- Good evening, we did a sweat test and they told us we were in the gray zone twice. They gave us a genetic test. The child doesn't have any clinical picture at all, respiratory problems, etc., only he is off the curve in height and weight a little above the red line. Please, because I'm about to go crazy. Could the borderline test be nothing? Could the genetic test be good?
- 09.03.2025
- Pregnancy - Combination of parents with deltaF508 & c.3623G>A
- First of all, congratulations to your team for creating this useful site. We are in the 3rd month of pregnancy and in a 99% test of the cystic fibrosis gene in both of us, the c.3623G>A (rs746103666) change was found in heterozygosity in the father and the F580del mutation in the mother. The nucleotide change in the father is reported as of unknown clinical significance. The mother's is clearly related to the most common mutation for CF. We visited a clinical geneticist and after searching the databases, it emerged that the father's change is now characterized by some centers as possibly pathogenic, while a case of a sick infant in America with a mild form of CF has also been recorded. We are going to have the fetus tested in the immediate future. However, in the case where the fetus has received both changes, we feel that we have not received enough information to make a decision about continuing the pregnancy. According to the geneticist, there is no data that could help us because the father's change is considered rare and no cases have been recorded. Is there a center or medical specialty that could give us more information about the possible complications and their severity, for a child with our combination of changes or even about what mild CF disease means? Thank you very much!
- 09.03.2025
- c.3154T>G (p.Phe1052Val)
- Good morning, during the prenatal checkup we did the cystic fibrosis test and both my husband and I were 100% positive and we were both heterozygous for the c.3154T>G (p.Phe1052Val, rs150212784) variant. If the child turns out to be homozygous for c.3154T>G (p.Phe1052Val, rs150212784) what problems might he have? Thank you very much in advance
- 05.03.2025
- pancreatitis / Cystic fibrosis
- Good evening. I am 11 weeks pregnant and the cystic fibrosis test showed the following: No pathogenic or likely pathogenic variant mediating the classic cystic fibrosis disease was detected in the examined sample. The examined sample carries the mild variant c.3705T>G (p.Ser1235Arg, rs34911792) in heterozygosity, which is characterized as non-pathogenic with regard to the manifestation of cystic fibrosis from the CFTR2 genotype-phenotype association database (non CF-causing). Based on the international scientific literature, the p.Ser1235Arg allele may be a risk factor for the occurrence of clinical conditions that have been associated with mutations of the CFTR gene (CFTR-Related Disorders) such as pancreatitis alone or together with variants of other genes involved in the occurrence of pancreatitis. (PMID: 11186891, 25799511, 25033378 ) Now the husband will also be examined. In case a mutation is found in him, is it dangerous? Or must exactly the same heterozygotes be found??
- 05.03.2025
- Cystic Fibrosis
- In a MOLECULAR TEST OF MUTATIONS OF ALL CODING REGIONS OF THE CFTR GENE WITH Next Generation Sequencing that I did, the result was: In the sent material, no mutation was detected that is associated with a typical Cystic Fibrosis phenotype. However, in the other findings it was written that the nucleotide change c.2002C>T (p.Arg668Cys) was detected in a heterozygous state. I would like to know what this means? and if there is a problem in future pregnancies.?
- 05.03.2025
- Cystic Fibrosis
- My husband was found to be heterozygous for the f1052v variant located in exon 20 of the cystic fibrosis gene. And I was found to be heterozygous for the c.1558G>A variant located in exon 11 of the cystic fibrosis gene. I am 18 weeks pregnant. What could happen to my baby?
- 05.03.2025
- Cystic Fibrosis
- Hello doctor. I am 12 weeks pregnant and I took the CF test at 99.6% and the following result was obtained: The tested sample did not detect any pathogenic or likely pathogenic mutation that mediates the classic CF disease. The tested sample is heterozygous for the p.Pro750Leu (c.2249C>T, rs140455771) variant of the CFTR gene (NM_000492.4) which is characterized as having multiple effects by the CFTR2 genotype-clinical phenotype association database. The clinvar database has conflicting reports regarding the possible pathogenicity of the mutation: 1 entry as pathogenic, 12 as probably pathogenic and 5 as of unknown clinical significance. Based on the current literature, the above variant appears to be positively associated with congenital absence of the seminiferous tubules. We were recommended genetic counseling. Our doctor urged us to have our husband do the full test. We received the first results where he had done the ΔF508del and it came out negative. Is there a chance that the mutation I have is pathogenic and the fetus will suffer from CF? Would a mutation on the husband's side have a negative outcome? Thank you
- 05.03.2025
- Genetic counselling - Parents carriers of cystic fibrosis mutations
- Good morning, I am in the 1st trimester of my second pregnancy. Both my husband and I carry cystic fibrosis mutations. (Husband in 95% resolution carries the change c.476T>C, while I carry D614G). Our first child did not inherit any of these (as we knew after trophoblast testing & karyotyping) and is perfectly healthy. In this pregnancy, recommendation is to receive trophoblast testing again, which I will certainly do. My question is, what is the genetic counseling if the fetus is at 25% and inherits both changes? As far as we were informed in the 1st pregnancy, there is no recorded case in the literature of the appearance of a typical form of the disease with these combinations. Thank you, Christine
- 07.10.2024
- mutation c.3154T>G (p.Phe1052Val)
- Good morning, in the prenatal checkup we did the cystic fibrosis carrier testing and me and my husband (testing at 100% ) were both heterozygous carriers for the variant c.3154T>G (p.Phe1052Val, rs150212784). If the child is homozygous for c.3154T>G (p.Phe1052Val, rs150212784) what problems might he have? Thank you very much in advance
- 07.10.2024
- Chance of CF in the fetus
- Hello, in the prenatal test for me, the mutation c.2620-15C>G in the CFTR gene was found, which is characterized as a possibly non-pathogenic polymorphism, and for my husband, c.3718-24G>A was found, which is characterized as possibly non-pathogenic/unspecified of clinical significance. What is the probability that the fetus will show both polymorphisms and what is the probability that it will suffer from CF.
- 22.09.2024